Reference health
Pan-Cancer Landscape of Aberrant DNA Methylation across Human Tumors
83/83 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
The 83 checked references that resolve
resolves10.1158/0008-5472.CAN-04-4283
<i>EMP3</i>, a Myelin-Related Gene Located in the Critical 19q13.3 Region, Is Epigenetically Silenced and Exhibits Features of a Candidate Tumor Suppressor in Glioma and Neuroblastoma
resolves10.1093/nar/gkn673
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
resolves10.1093/nar/gkw709
Mammalian PNLDC1 is a novel poly(A) specific exonuclease with discrete expression during early development
resolves10.1186/s13059-017-1349-1
xCell: digitally portraying the tissue cellular heterogeneity landscape
resolves10.1016/j.cell.2018.02.060
Comprehensive Characterization of Cancer Driver Genes and Mutations
resolves10.1038/nature08460
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
resolves10.1038/nrc3130
A decade of exploring the cancer epigenome — biological and translational implications
resolves10.1074/jbc.M112.385658
The Ciliary Protein Nephrocystin-4 Translocates the Canonical Wnt Regulator Jade-1 to the Nucleus to Negatively Regulate β-Catenin Signaling
resolves10.1056/NEJMoa1402121
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
resolves10.1038/nature11252
Comprehensive molecular characterization of human colon and rectal cancer
resolves10.1158/2159-8290.CD-12-0095
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
resolves10.1016/j.ccr.2011.11.006
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
resolves10.1038/srep22113
The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma
resolves10.1038/ncb3389
Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
resolves10.1016/S1074-7613(00)80399-4
The Novel Receptor TRAIL-R4 Induces NF-κB and Protects against TRAIL-Mediated Apoptosis, yet Retains an Incomplete Death Domain
resolves10.1186/s13073-017-0419-z
Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas
resolves10.1016/j.yexmp.2015.01.013
Downregulation of HTATIP2 expression is associated with promoter methylation and poor prognosis in glioma
resolves10.1038/ng.3940
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor
resolves10.1073/pnas.91.21.9700
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
resolves10.1371/journal.pone.0008357
Analysis of the Association between CIMP and BRAFV600E in Colorectal Cancer by DNA Methylation Profiling
resolves10.1016/j.cell.2016.02.065
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
resolves10.1093/bioinformatics/btu316
A systems-level integrative framework for genome-wide DNA methylation and gene expression data identifies differential gene expression modules under epigenetic control
resolves10.1128/MCB.22.14.5203-5211.2002
Novel Transcription Coactivator Complex Containing Activating Signal Cointegrator 1
resolves10.1158/1078-0432.CCR-11-2322
Wnt-Pathway Activation in Two Molecular Classes of Hepatocellular Carcinoma and Experimental Modulation by Sorafenib
resolves10.1038/nature12213
Mutational heterogeneity in cancer and the search for new cancer-associated genes
resolves10.1074/jbc.M809752200
HSCARG Regulates NF-κB Activation by Promoting the Ubiquitination of RelA or COMMD1
resolves10.1016/j.cell.2016.09.018
Ever-Changing Landscapes: Transcriptional Enhancers in Development and Evolution
resolves10.1016/j.cell.2018.03.034
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
resolves10.1016/j.ccell.2017.06.010
Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies
resolves10.1016/j.ccr.2010.03.017
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
resolves10.1016/j.cell.2012.10.028
Convergent Multi-miRNA Targeting of ApoE Drives LRP1/LRP8-Dependent Melanoma Metastasis and Angiogenesis
resolves10.1002/hep.28684
Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin‐6 signaling in hepatocellular carcinoma
resolves10.7554/eLife.26476
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
resolves10.1038/modpathol.2015.144
High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing
resolves10.1016/j.cell.2018.03.026
Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade
resolves10.1371/journal.pone.0179501
Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells
resolves10.1126/science.aak9510
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
resolves10.1016/j.ygyno.2017.03.034
BRCA1 and RAD51C promoter hypermethylation confer sensitivity to the PARP inhibitor rucaparib in patients with relapsed, platinum-sensitive ovarian carcinoma in ARIEL2 Part 1
resolves10.1186/gm323
Epigenetic variability in cells of normal cytology is associated with the risk of future morphological transformation
resolves10.1073/pnas.091062498
Significance analysis of microarrays applied to the ionizing radiation response
resolves10.1126/science.aad0095
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
resolves10.1016/j.canlet.2017.03.029
Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes
resolves10.1038/nrneurol.2009.197
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
resolves10.1038/sj.onc.1207076
PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model
resolves10.1038/nrg2905
Charting histone modifications and the functional organization of mammalian genomes
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1016/j.celrep.2018.09.082"><img src="https://citestamp.com/citestamped/10.1016/j.celrep.2018.09.082/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1016/j.celrep.2018.09.082)